PlexinA2 and PlexinA4, known Sema6A receptors [39-40], showed differential expression in BRAF-mutant clones and melanomas, indicating that in such tumors only Plexin-A4 acted as Sema6A receptor. This evidence concerns the gene BRAF and melanoma.